Co-ordination Group for Mutual Recognition (MRP) and Decentralised Procedures (DCP)
The CMDh (Co-ordination Group for Mutual Recognition (MRP) and Decentralised Procedures (DCP)) is an intergovernmental committee that is responsible for the co-ordination of all issues in connection with the licensing and pharmacovigilance of medicinal products that have been or will be granted a national marketing authorisation in more than one Member State of the European Union/the European Economic Area (EEA).
Each country of the European Economic Area appoints a scientific delegate to the CMDh who represents the corresponding Member State. The MR Index provides an overview of all medicinal products licensed via MRP and DCP. For further information on this committee please visit the CMDh.